Milestone Accounts Payable from 2010 to 2024

MIST Stock  USD 1.85  0.01  0.54%   
Milestone Pharmaceuticals Accounts Payable yearly trend continues to be comparatively stable with very little volatility. Accounts Payable will likely drop to about 3.6 M in 2024. Accounts Payable is the amount Milestone Pharmaceuticals owes to suppliers or vendors for products or services received but not yet paid for. It represents Milestone Pharmaceuticals' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2018-03-31
Previous Quarter
749 K
Current Value
1.6 M
Quarterly Volatility
1.5 M
 
Covid
Check Milestone Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Milestone Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 1.2 M or Interest Income of 3.7 M, as well as many indicators such as Price To Sales Ratio of 75.32, Dividend Yield of 0.0 or PTB Ratio of 4.49. Milestone financial statements analysis is a perfect complement when working with Milestone Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Milestone Pharmaceuticals Correlation against competitors.
For more information on how to buy Milestone Stock please use our How to Invest in Milestone Pharmaceuticals guide.

Latest Milestone Pharmaceuticals' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Milestone Pharmaceuticals over the last few years. An accounting item on the balance sheet that represents Milestone Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Milestone Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Milestone Pharmaceuticals' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Milestone Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Milestone Accounts Payable Regression Statistics

Arithmetic Mean2,161,654
Geometric Mean1,630,614
Coefficient Of Variation74.25
Mean Deviation1,432,165
Median819,000
Standard Deviation1,605,059
Sample Variance2.6T
Range3.8M
R-Value0.80
Mean Square Error996B
R-Squared0.64
Significance0.0003
Slope287,345
Total Sum of Squares36.1T

Milestone Accounts Payable History

20243.6 M
2023M
20222.3 M
20214.4 M
20204.6 M
20194.4 M
20182.6 M

About Milestone Pharmaceuticals Financial Statements

Milestone Pharmaceuticals shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Milestone Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Milestone Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Milestone Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts PayableM3.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Milestone Stock Analysis

When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.